Urology · San Bernardino, CA
NPI
1760666499
Since 2007
Specialty
Urology
Code 208800000X
Group practices
8
Medicare group memberships
Hospitals
5
Hospital affiliations
489 E 21st St
San Bernardino, CA, 92404
Phone (909) 882-2973
Groups this clinician bills Medicare through
Medicare paid, 2024
$139K
1,405 services
Medicare patients, 2024
373
Average age 73
Drug cost, 2024
$1.5M
3,030 prescriptions
Company payments, 2025
$17K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steve Dong was code 99214 (office e&m - established), 343 times for 200 patients. In total Steve Dong billed 1,405 services in 72 codes, and Medicare paid $139K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 343 | 200 | $96.23 | $33K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 133 | 22 | $135.01 | $18K |
| 99213 Office E&M - Established | Office | 128 | 99 | $67.41 | $8,628 |
| 51798 Ultrasound - Nonspecific | Office | 62 | 52 | $9.18 | $569 |
| 99204 Office E&M - New | Office | 61 | 61 | $119.30 | $7,278 |
| 99223 Hospital E&M - Initial | Facility | 57 | 53 | $143.00 | $8,151 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 49 | 13 | $0.36 | $17.85 |
| 52000 Cystourethroscopy | Office | 44 | 44 | $193.21 | $8,501 |
| 96402 Chemotherapy Administration | Office | 44 | 21 | $30.73 | $1,352 |
| 51703 Other Organ Systems | Office | 42 | 22 | $124.95 | $5,248 |
| 51700 Other Organ Systems | Office | 39 | 20 | $42.10 | $1,642 |
| 99232 Hospital E&M - Subsequent | Facility | 13 | 12 | $65.05 | $846 |
By year: 2022 $130K for 1,188 services; 2023 $112K for 1,237 services; 2024 $139K for 1,405 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steve Dong prescribed most often to Medicare patients was Tamsulosin Hcl, with 470 prescriptions and refills. In total Steve Dong wrote 3,030 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 470 | 1,258 | 177 | $6,765 |
| Finasteride Generic | 403 | 1,122 | 144 | $5,659 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 308 | 310 | 205 | $799 |
| Ciprofloxacin Hcl Generic | 227 | 230 | 149 | $1,014 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 179 | 413 | 66 | $4,248 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 132 | 132 | 109 | $992 |
| Myrbetriq Mirabegron | 113 | 190 | 39 | $82K |
| Oxybutynin Chloride Generic | 82 | 179 | 30 | $1,836 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 76 | 80 | 43 | $886 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 72 | 72 | 32 | $315 |
| Bicalutamide Generic | 70 | 94 | 34 | $1,392 |
| Imipramine Hcl Generic | 65 | 142 | 27 | $2,856 |
| Gemtesa Vibegron | 65 | 142 | 18 | $65K |
| Sildenafil Citrate Generic | 55 | 69 | 20 | $278 |
| Methenamine Hippurate Generic | 54 | 97 | 19 | $4,805 |
Brand drugs: - claims; generic drugs: 2,720 claims; opioid claims: 183.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steve Dong $17K ($17K in general payments such as food, travel and fees) from 14 companies. The largest payer was Intuitive Surgical, Inc. with $16K.
| Company | Payments | Amount |
|---|---|---|
| Intuitive Surgical, Inc. ISRG | 7 | $16K |
| Abbvie Inc. ABBV | 9 | $214 |
| Janssen Biotech, Inc. JNJ | 7 | $191 |
| Urogen Pharma, Inc. URGN | 6 | $161 |
| Tolmar, Inc. | 3 | $101 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $78.06 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $65.25 |
| Dendreon Pharmaceuticals LLC | 3 | $60.33 |
| Immunitybio, Inc. IBRX | 2 | $40.67 |
| ConvaTec Inc. CTEC.L | 1 | $32.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.